Cyclical mastalgia and breast cancer risk: Results of a French cohort study

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 6, 2006, Pages 1229-1231

  Plu Bureau, Geneviève ^a,b   Lê, Monique G ^c   Sitruk Ware, Regine ^d   Thalabard, Jean Christophe ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b HÔTEL DIEU   (France)

^c INSERM   (France)

^d ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; FRANCE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MASTALGIA; ORAL CONTRACEPTION; PRIORITY JOURNAL;

ADULT; BIOPSY; BREAST DISEASES; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MENSTRUAL CYCLE; MENSTRUATION; MIDDLE AGED; RISK FACTORS;

EID: 33745726101     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0745     Document Type: Article

References (15)

1. Mansel RE. ABC of breast diseases. Breast pain BMJ 1994;309:866-8.
2. Hughes LE, Mansel RE, Webster DJT. Benign disorders and diseases of the breast concepts and clinical management. 2nd ed. London: WB Saunders; 2000.
3. Millet AV, Dirbas FM. Clinical management of breast pain: a review. Obstet Gynecol Surv 2002;57:451-61.
4. Wisbey J-R, Mansel R-E, Pye J-K, Kumar S, Preece RE, Hughes LE. Natural history of breast pain. Lancet 1983;ii:672-4.
5. Klimberg SV. Etiology and management of breast pain. In: Bland KL, Copeland EM, editors. The breast: comprehensive management of benign and malignant diseases. 2nd ed. Philadelphia: WB Saunders Co; 1988. pp. 247-60.
6. Wang FY, Fentiman IS. Epidemiology and endocrinology of benign breast disease. Breast cancer Res Treat 1985;6:5-36.
7. Plu-Bureau G, Thalabard JC, Sitruk-Ware R, Asselain B, Mauvais-Jarvis PM. Cyclical mastalgia as a marker of breast cancer susceptibility: results of a case-control study among French women. Br J Cancer 1992;65:945-9.
8. Goodwin PJ, Deboer G, Clark RM. Cyclical mastopathy and premenopausal breast cancer risk: results of a case-control study. Breast Cancer Res Treat 1994;33:63-73.
9. Plu- Bureau G, Le M, Sitruk-Ware R, Thalabard JC, Mauvais-Jarvis PM. Progestogen use and risk of breast cancer in a cohort study of premenopausal women with benign breast disease. Br J Cancer 1994;70:270-7.
10. Plu-Bureau G, Le M, Thalabard JC, Sitruk-Ware R, Mauvais-Jarvis P. Percutaneous progesterone uses and risk of breast cancer: results from a French cohort study of premenopausal women with benign breast disease. Cancer Detect Prev 1999;23:290-6.
11. Haagensen CD. Physician's role in the detection and diagnosis of breast disease. In: Haagensen CD, editor. Diseases of the breast. Philadelphia: Saunders WB; 1971. p. 99-148.
12. Cox DR. Regression models and life tables. J R Stat Soc 1972;2:187-220.
13. R statistical package Release 2.0.0.1 http://www.r-project.org.
14. Thiebaut AC, Benichou J. Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Stat Med 2004;23:3803-20.
15. Khan SA, Apkarian AV. Mastalgia and breast cancer: a protective association? Cancer Detect Prev 2002;26:192-6.